![]() |
市场调查报告书
商品编码
1451517
2024-2032 年代怀孕市场报告(按类型(妊娠代孕、传统代孕)、技术(IVF 与 ICSI、IVF 与 ICSI、子宫内人工授精)、服务提供者(医院、生育诊所等)和地区Surrogacy Market Report by Type (Gestational Surrogacy, Traditional Surrogacy), Technology (IVF with ICSI, IVF without ICSI, Intrauterine Insemination), Service Provider (Hospitals, Fertility Clinics, and Others), and Region 2024-2032 |
2023年全球代孕市场规模达1.834亿美元。展望未来, IMARC Group预计到2032年市场规模将达到3.069亿美元,2024-2032年复合年增长率(CAGR)为5.8%。生育旅游的迅速扩张、受孕困难的增加、具有成本效益的代孕的容易获得以及许多国家管理当局提供的优惠报销政策是推动该市场的一些主要因素。
代孕是一种生殖安排,其中被称为代孕者或怀孕携带者的妇女同意为另一个人或夫妇怀孕和生下孩子。面临生育挑战或阻止怀孕的医疗状况的个人或夫妇经常寻求这种方法。代孕有两种主要类型:传统代孕,使用代孕妈妈的卵子;妊娠代孕,使用预期母亲的卵子或捐赠卵子创建胚胎,然后植入代孕妈妈的子宫。代孕涉及法律协议、医疗程序和情感考虑,其合法性因司法管辖区而异。
人们对生育挑战的认识不断增强,对非传统家庭结构的接受度不断提高,将刺激预测期内代孕市场的成长。面临生殖障碍的夫妻和个人将代孕视为满足其为人父母愿望的可行解决方案。此外,生殖技术和医疗程序的许多进步,加上某些地区法律框架的改进,促进了更安全、更可靠的代孕安排,正在对市场成长产生积极影响。除此之外,快速的全球化和便利的国际旅行使有意父母能够在监管有利且成本较低的国家探索代孕选择,从而推动市场成长。此外,不断增长的支持网络、倡导团体和线上平台为那些考虑代孕的人提供资讯和情感帮助,加快了产品的采用率。此外,不断发展的延迟生育文化转变和不孕症病例的增加也促进了市场的成长。
提高接受度和意识
由于代孕作为成为父母的合法途径的接受度和意识不断增强,代孕市场正在经历一场变革。随着社会态度的不断变化和对生育挑战的更加开放的讨论,代孕在全球范围内获得了巨大的信誉和认可。这一趋势的基础是人们对多样化家庭结构的日益认识以及接受替代生殖方法的意愿增强。因此,越来越多的个人和夫妇正在探索代孕作为可行的解决方案,为代孕服务创造了更广泛、更容易接受的市场。
医疗科技的进步
医疗技术的重大进步彻底改变了代孕格局。体外受精(IVF)和妊娠代孕等技术在世界各地变得越来越复杂和容易取得。这些创新可以精确控制代孕过程,有助于提高代孕母亲和预期父母的成功率并降低医疗风险。先进的产前检测和医学监测进一步提高代孕安排的安全性和成功率。这一趋势使个体面临生育挑战,并将代孕定位为更广泛的辅助生殖领域中更可行和更有效的选择。
跨国代孕安排不断增加
由于不同国家代孕法律的差异,代孕市场的特征是跨国安排显着增加。来自代孕法规受到限制的各国的意向父母正在法律环境更有利的司法管辖区寻求代孕服务。这刺激了对专家咨询服务的需求,以应对国际代孕过程中复杂的法律、文化和后勤考虑。它强调了代孕市场的全球性,并强调在寻求跨国代孕时采取明智方法的必要性,确保遵守法律框架,同时维护所有相关利害关係人的利益。
The global surrogacy market size reached US$ 183.4 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 306.9 Million by 2032, exhibiting a growth rate (CAGR) of 5.8% during 2024-2032. The rapid expansion of fertility tourism, rising inability to conceive, easy availability of cost-effective surrogacy, and favorable reimbursement policies offered by governing authorities of numerous countries are some of the major factors propelling the market.
Surrogacy is a reproductive arrangement in which a woman, known as the surrogate or gestational carrier, agrees to carry and give birth to a child for another individual or couple. This method is often sought by individuals or couples facing fertility challenges or medical conditions that prevent pregnancy. There are two primary types of surrogacy: traditional surrogacy, where the surrogate's egg is used, and gestational surrogacy, where the embryo is created using either the intended mother's egg or a donor egg, and then implanted into the surrogate's uterus. Surrogacy involves legal agreements, medical procedures, and emotional considerations, and its legality varies across jurisdictions.
The increasing awareness of fertility challenges and the rising acceptance of non-traditional family structures will stimulate the growth of the surrogacy market during the forecast period. Couples and individuals facing reproductive obstacles see surrogacy as a viable solution to fulfill their desire for parenthood. Moreover, numerous advancements in reproductive technologies and medical procedures, coupled with improved legal frameworks in certain regions, that facilitate safer and more reliable surrogacy arrangements are positively influencing the market growth. Apart from this, rapid globalization and ease of international travel have enabled intended parents to explore surrogacy options in countries with favorable regulations and lower costs, thereby propelling the market growth. Additionally, the growing support networks, advocacy groups, and online platforms provide information and emotional assistance to those considering surrogacy has accelerated the product adoption rate. Furthermore, the evolving cultural shift toward delayed parenthood and the rising instances of infertility are contributing to the market growth.
Increasing Acceptance and Awareness
The surrogacy market is experiencing a transformative shift due to the expanding acceptance and awareness of surrogacy as a legitimate path to parenthood. With evolving social attitudes and a more open discourse around fertility challenges, surrogacy has gained immense credibility and recognition across the globe. This trend is underpinned by a growing recognition of diverse family structures and an increased willingness to embrace alternative reproductive methods. As a result, more individuals and couples are exploring surrogacy as a viable solution, creating a broader and more receptive market for surrogacy services.
Advancements in medical technology
The surrogacy landscape has been revolutionized by significant advancements in medical technology. Techniques such as in vitro fertilization (IVF) and gestational surrogacy have become increasingly sophisticated and accessible worldwide. These innovations enable precise control over the surrogacy process, contributing to improved success rates and reduced medical risks for both surrogate mothers and intended parents. Advanced prenatal testing and medical monitoring further enhance the safety and success of surrogacy arrangements. This trend empowers individuals with fertility challenges and positions surrogacy as a more viable and efficient option within the broader spectrum of assisted reproduction.
Rising cross-border surrogacy arrangements
The surrogacy market is marked by a notable rise in cross-border arrangements, driven by the disparities in surrogacy laws across different countries. Intended parents from various nations with restrictive surrogacy regulations are seeking surrogacy services in jurisdictions with more favorable legal environments. This has spurred the need for expert consulting services that navigate the complex web of legal, cultural, and logistical considerations in international surrogacy journeys. It underscores the global nature of the surrogacy market and emphasizes the necessity for a well-informed approach when pursuing cross-border surrogacy, ensuring compliance with legal frameworks while safeguarding the interests of all stakeholders involved.
IMARC Group provides an analysis of the key trends in each segment of the global surrogacy market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, technology and service provider.
Gestational Surrogacy
Traditional Surrogacy
Gestational surrogacy dominates the market
The report has provided a detailed breakup and analysis of the market based on the type. This includes gestational surrogacy and traditional surrogacy. According to the report, gestational surrogacy represented the largest segment.
Gestational surrogacy method, where a surrogate carries a pregnancy conceived using the intended parents' or donors' eggs and sperm, offers distinct advantages. It minimizes genetic ties between the surrogate and the child, addressing legal and emotional complexities. Gestational surrogacy also opens doors for individuals and couples facing fertility challenges, same-sex couples, and those seeking genetic diversity.
Moreover, the increasing precision of assisted reproductive technologies, such as in vitro fertilization (IVF), is propelling the success rates of gestational surrogacy. As a result, it provides a viable solution for intended parents and fosters a broader acceptance of surrogacy due to its streamlined legal and genetic frameworks, thus playing a pivotal role in driving the market forward.
IVF with ICSI
IVF without ICSI
Intrauterine Insemination
IVF with ICSI holds the largest share in the market
A detailed breakup and analysis of the market based on the technology has also been provided in the report. This includes IVF with ICSI, IVF without ICSI, and intrauterine insemination. According to the report, IVF with ICSI accounted for the largest market share.
IVF with Intracytoplasmic Sperm Injection (ICSI) is an advanced assisted reproductive technique that addresses male infertility challenges by directly injecting a single sperm into an egg, optimizing fertilization. This precision enhances the chances of obtaining viable embryos for transfer, thus increasing the success rates of surrogacy arrangements. IVF with ICSI enables intended parents to overcome complex fertility issues, expanding the pool of potential clients for surrogacy services.
Moreover, the higher success rates associated with this technique encourage intended parents to consider surrogacy as a reliable pathway to parenthood, fostering greater demand within the surrogacy market. The integration of IVF with ICSI enhances the medical feasibility of surrogacy and strengthens its reputation as an effective solution, fueling the market growth.
Hospitals
Fertility Clinics
Others
Fertility Clinics represent the most popular service provider
The report has provided a detailed breakup and analysis of the market based on the service provider. This includes hospitals, fertility clinics, and others. According to the report, fertility clinics represented the largest segment.
Fertility clinics play a pivotal role in propelling the market growth by providing essential medical expertise and infrastructure. These clinics offer a spectrum of advanced reproductive technologies, including in vitro fertilization (IVF) and embryo transfer procedures, which are fundamental to surrogacy. Their specialized services cater to individuals and couples facing infertility challenges, making surrogacy a viable option. Fertility clinics provide comprehensive medical assessments, personalized treatment plans, and close monitoring throughout the surrogacy journey, ensuring the best possible outcomes.
Additionally, these clinics often collaborate with surrogacy agencies and legal experts, creating a seamless experience for intended parents and surrogates. As hubs of medical innovation and support, fertility clinics significantly the market growth by enabling successful pregnancies, facilitating family expansion, and nurturing the partnership between intended parents and surrogates.
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
North America exhibits a clear dominance in the market
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America accounted for the largest market share.
North America held the biggest share in the market due to its favorable legal, medical, and social landscape. The region's well-established regulatory frameworks in countries like the United States and Canada provide a secure environment for surrogacy arrangements, assuring the rights of intended parents and surrogates, thereby propelling the market growth in North America. Advanced medical facilities and expertise in assisted reproductive technologies, coupled with a culturally accepting environment in North America, attract both domestic and international individuals and couples seeking surrogacy services.
Additionally, the region's diverse population and evolving perspectives on family structures has accelerated the adoption of surrogacy. As a result, North America emerges as a prominent hub within the surrogacy domain, catering to a wide range of intended parents while upholding ethical standards and legal protections.
Key players in the market are driving innovation through a range of strategies. Prominent surrogacy agencies are embracing digital platforms, streamlining communication between intended parents, surrogates, and medical professionals. They are also integrating advanced embryo screening techniques to enhance success rates and reduce the likelihood of genetic disorders. Some key players are exploring eco-friendly practices by incorporating sustainable approaches in fertility treatments. Collaborations with fertility clinics and legal experts are becoming more prevalent to ensure adherence to evolving regulatory frameworks. These innovations collectively underscore the commitment of key players to continually elevate the surrogacy experience through technological, medical, and holistic advancements. We also expect the market to witness new entrants, consolidation of portfolios, and increased collaborations to drive healthy competition within the domain.
Bourn Hall Clinic
CARE Fertility
Circle Surrogacy & Egg Donation
Extraordinary Conceptions
Growing Generations LLC
Houston Fertility Center
IVIRMA Global
Max Healthcare
New Hope Fertility Center
Nova IVF
Ovation Fertility
Scanfert Clinic
In June 2021, Circle Surrogacy & Egg Donation sponsored A Lifetime of Pride and Joy, a campaign that celebrates and encourages family equality by raising awareness around the accessibility of fertility care among the LGBTQ+ population. This impactful campaign is dedicated to the celebration and advancement of family equality, while also shedding light on the crucial aspect of accessible fertility care. By participating in this campaign, Circle Surrogacy takes a resolute stance in promoting inclusivity and understanding, embracing the diversity of modern families.
In June 2023, AHH's Nova IVF Fertility, a pioneering name in the realm of assisted reproductive healthcare, unveiled an ambitious roadmap that envisages the establishment of an impressive network of 100 centers within the next four years. This strategic expansion plan, as reported by the Economic Times, reflects the organization's unwavering commitment to providing accessible and advanced fertility care across India.
In October 2022, Ovation Fertility, a leading name in the field of assisted reproductive technology, unveiled an exciting and transformative partnership with Genomic Prediction. This collaboration marks a significant milestone in the realm of genetic testing, as it promises to not only enhance but also expand the horizons of genetic assessment within the domain of fertility and family planning. The alliance between Ovation(R) Fertility and Genomic Prediction showcases a shared commitment to leveraging cutting-edge scientific advancements to empower intended parents with a deeper understanding of their genetic profile and reproductive options.